A retrospective study comparing the anti-vascular endothelial growth factor (anti-VEGF) monotherapy with anti-VEGF therapy combined with sub-Tenon's capsule injections of triamcinolone acetonide (STTA) in patients with macular edema (ME) associated with branch retinal vein occlusion (BRVO)
Latest Information Update: 31 Aug 2021
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone (Primary)
- Indications Retinal oedema
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2021 New trial record